THE IMPACT OF LIRAGLUTIDE ON PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE

被引：0
|
作者：
Lee, Hye Won [1 ]
So, Jae Eun [1 ]
Ahn, Sang Hoon [1 ]
Kim, Seung Up [1 ]
机构：
[1] Yonsei Univ, Coll Med, Seoul, South Korea
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1619
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Impact of hypertension on liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease
    Gao, Zhifeng
    Deng, Huan
    Qin, Bowen
    Bai, Liang
    Li, Jiangwei
    Zhang, Jian
    FRONTIERS IN MEDICINE, 2025, 12
  • [2] Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact
    Tang, Si-Ying
    Tan, Jian Shiun
    Pang, Xian-Zheng
    Lee, Guan-Huei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (03) : 549 - 560
  • [3] Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact
    Si-Ying Tang
    Jian Shiun Tan
    Xian-Zheng Pang
    Guan-Huei Lee
    World Journal of Gastroenterology, 2023, 29 (03) : 549 - 560
  • [4] Evaluation of the Impact of Metabolic Syndrome on Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
    Kani, Haluk Tarik
    Demirtas, Coskun Ozer
    Keklikkiran, Caglayan
    Ergenc, Ilkay
    Mehdiyev, Shahin
    Akdeniz, Esra
    Yilmaz, Yusuf
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2021, 32 (08): : 661 - 666
  • [5] Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease
    Cheng, Yu-Ming
    Hsieh, Tsung-Han
    Wang, Chia-Chi
    Kao, Jia-Horng
    JHEP REPORTS, 2023, 5 (09)
  • [6] Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
    Min Kyu Kang
    Yu Rim Lee
    Se Young Jang
    Won Young Tak
    Young Oh Kweon
    Jeong Eun Song
    Rohit Loomba
    Soo Young Park
    Jung Gil Park
    Hepatology International, 2023, 17 : 626 - 635
  • [7] Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
    Kang, Min Kyu
    Lee, Yu Rim
    Jang, Se Young
    Tak, Won Young
    Kweon, Young Oh
    Song, Jeong Eun
    Loomba, Rohit
    Park, Soo Young
    Park, Jung Gil
    HEPATOLOGY INTERNATIONAL, 2023, 17 (03) : 626 - 635
  • [8] The impact of metabolic dysfunction–associated fatty liver disease on the prognosis of patients with hepatocellular carcinoma after radical resection
    Ke-Gong Xiong
    Kun-Yu Ke
    Li-Fang Chen
    Jin-Feng Kong
    Tai-Shun Lin
    Qing-Biao Lin
    Su Lin
    Yue-Yong Zhu
    Hepatobiliary&PancreaticDiseasesInternational, 2023, 22 (04) : 366 - 372
  • [9] The importance and impact of recognizing metabolic dysfunction-associated fatty liver disease in patients with chronic hepatitis C
    Al-Omary, Ahmed
    Byth, Karen
    Weltman, Martin
    George, Jacob
    Eslam, Mohammed
    JOURNAL OF DIGESTIVE DISEASES, 2022, 23 (01) : 33 - 43
  • [10] Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma
    Zhu, Ji-Qiao
    Liu, Jia-Zong
    Yang, Shi-Wei
    Ren, Zhang-Yong
    Ye, Xiao-Yong
    Liu, Zhe
    Li, Xian-Liang
    Han, Dong-Dong
    He, Qiang
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
12345